FDA Approved: DECITABINE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for Decitabine submitted by Mylan Institutional LLC under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

SUPPL AP for DECITABINE (DECITABINE)